BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 32407621)

  • 1. Glycan-Mediated Technology for Obtaining Homogeneous Site-Specific Conjugated Antibody-Drug Conjugates: Synthesis and Analytical Characterization by Using Complementary Middle-up LC/HRMS Analysis.
    Duivelshof BL; Deslignière E; Hernandez-Alba O; Ehkirch A; Toftevall H; Sjögren J; Cianferani S; Beck A; Guillarme D; D'Atri V
    Anal Chem; 2020 Jun; 92(12):8170-8177. PubMed ID: 32407621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of an antibody-drug conjugate by hydrophilic interaction chromatography coupled to mass spectrometry.
    D'Atri V; Fekete S; Stoll D; Lauber M; Beck A; Guillarme D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():37-41. PubMed ID: 29477065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-Dimensional Liquid Chromatography Coupled to High-Resolution Mass Spectrometry for the Analysis of ADCs.
    Chapel S; Rouvière F; Sarrut M; Heinisch S
    Methods Mol Biol; 2020; 2078():163-185. PubMed ID: 31643056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Combination of Native LC-MS Approaches for the Comprehensive Characterization of the Antibody-Drug Conjugate Trastuzumab Deruxtecan.
    Deslignière E; Diemer H; Erb S; Coliat P; Pivot X; Detappe A; Hernandez-Alba O; Cianférani S
    Front Biosci (Landmark Ed); 2022 Oct; 27(10):290. PubMed ID: 36336868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometry.
    Friese OV; Smith JN; Brown PW; Rouse JC
    MAbs; 2018 Apr; 10(3):335-345. PubMed ID: 29393747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
    Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
    Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
    Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
    MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate determination of drug-to-antibody ratio of interchain cysteine-linked antibody-drug conjugates by LC-HRMS.
    Li K; Zhang Z; Lin ZJ; Shi H; Ma Y
    Anal Bioanal Chem; 2020 Feb; 412(4):833-840. PubMed ID: 31872274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjugation site analysis of antibody-drug-conjugates (ADCs) by signature ion fingerprinting and normalized area quantitation approach using nano-liquid chromatography coupled to high resolution mass spectrometry.
    Sang H; Lu G; Liu Y; Hu Q; Xing W; Cui D; Zhou F; Zhang J; Hao H; Wang G; Ye H
    Anal Chim Acta; 2017 Feb; 955():67-78. PubMed ID: 28088282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Custom-Designed Affinity Capture LC-MS F(ab')2 Assay for Biotransformation Assessment of Site-Specific Antibody Drug Conjugates.
    Su D; Ng C; Khosraviani M; Yu SF; Cosino E; Kaur S; Xu K
    Anal Chem; 2016 Dec; 88(23):11340-11346. PubMed ID: 27779866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
    Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. State-of-the-Art Native Mass Spectrometry and Ion Mobility Methods to Monitor Homogeneous Site-Specific Antibody-Drug Conjugates Synthesis.
    Deslignière E; Ehkirch A; Duivelshof BL; Toftevall H; Sjögren J; Guillarme D; D'Atri V; Beck A; Hernandez-Alba O; Cianférani S
    Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34073805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of drug-to-antibody ratio of antibody-drug conjugate in biological samples using microflow-liquid chromatography/high-resolution mass spectrometry.
    Inoue K; Mochizuki T; Kasamori N; Komori T
    Bioanalysis; 2022 Dec; 14(24):1533-1545. PubMed ID: 36825963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Analysis of Reduced Antibody Drug Conjugate by Online LC-MS/MS with Fourier Transform Ion Cyclotron Resonance Mass Spectrometry.
    Larson EJ; Zhu Y; Wu Z; Chen B; Zhang Z; Zhou S; Han L; Zhang Q; Ge Y
    Anal Chem; 2020 Nov; 92(22):15096-15103. PubMed ID: 33108180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.
    Chen B; Lin Z; Zhu Y; Jin Y; Larson E; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
    Anal Chem; 2019 Sep; 91(18):11661-11669. PubMed ID: 31442030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific glycan-conjugated NISTmAb antibody drug conjugate mimetics: synthesis, characterization, and utility.
    Agnew B; Lin S; Zhang T; Aggeler R; Mouchahoir T; Schiel J
    Anal Bioanal Chem; 2021 Aug; 413(20):4989-5001. PubMed ID: 34231000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insights from native mass spectrometry approaches for top- and middle- level characterization of site-specific antibody-drug conjugates.
    Botzanowski T; Erb S; Hernandez-Alba O; Ehkirch A; Colas O; Wagner-Rousset E; Rabuka D; Beck A; Drake PM; Cianférani S
    MAbs; 2017 Jul; 9(5):801-811. PubMed ID: 28406343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Universal Affinity Capture Liquid Chromatography-Mass Spectrometry Assay for Evaluation of Biotransformation of Site-Specific Antibody Drug Conjugates in Preclinical Studies.
    Kotapati S; Passmore D; Yamazoe S; Sanku RKK; Cong Q; Poudel YB; Chowdari NS; Gangwar S; Rao C; Rangan VS; Cardarelli PM; Deshpande S; Strop P; Dollinger G; Rajpal A
    Anal Chem; 2020 Jan; 92(2):2065-2073. PubMed ID: 31860282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of drug load variants in a thiol linked antibody-drug conjugate using multidimensional chromatography.
    Gilroy JJ; Eakin CM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():182-189. PubMed ID: 28622622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.